In Vivo Efficacy of ABT-255 against Drug-Sensitive and -Resistant Mycobacterium tuberculosis Strains

Current therapy for pulmonary tuberculosis involves 6 months of treatment with isoniazid, pyrazinamide, rifampin, and ethambutol or streptomycin for reliable treatment efficacy. The long treatment period increases the probability of noncompliance, leading to the generation of multidrug-resistant iso...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Oleksijew, Andy, Meulbroek, Jon, Ewing, Patty, Jarvis, Ken, Mitten, Mike, Paige, Lenette, Tovcimak, Ann, Nukkula, Mike, Chu, Daniel, Alder, Jeffrey D.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 1998
Témata:
Experimental Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC105917/
https://ncbi.nlm.nih.gov/pubmed/9756775
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky